pillbase.ru

VANFLYTA

Active substance: quizartinib

TABLET, FILM COATED · QUIZARTINIB DIHYDROCHLORIDE 26.5 mg/1

United StatesActive

Marketing holder: Daiichi Sankyo Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Vanflyta
    quizartinib dihydrochloride
    EMEA/H/C/005910
    Daiichi Sankyo Europe GmbH
  • Vanflyta
    quizartinib dihydrochloride
    EMEA/H/C/004468
    Daiichi Sankyo Europe GmbH
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-98f4-7490-bb9c-eef6239ff0f0,01a12096-e8aa-75ff-b76f-6ad4378713c0;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
65597-511
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 65597-511 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 65597-511 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 65597-511 · Verified 2026-10-09 · open in source